Authors : Divyansh Singh; Pushpendra Kannojia; Prashant Kumar Sharma

Volume/Issue : Volume 11 - 2026, Issue 4 - April

Google Scholar : https://tinyurl.com/mpd42a5r

Scribd : https://tinyurl.com/yr8t58n2

DOI : https://doi.org/10.38124/ijisrt/26apr2103

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : In traditional healthcare systems for centuries Herbal medicines have been widely used for the prevention of various diseases. natural origin shows fewer side effects in neurological disorders such as depression and anxiety. herbal products for therapeutic efficacy depend largely on standardization and scientific validation. Some processing methods may affect the quality like harvesting time, environmental conditions. herbal formulations for standardization of involves the assessment of physicochemical parameters, organoleptic characteristics, phytochemical screening, and using modern analytical techniques, chromatographic fingerprinting such as High-Performance High Performance Liquid Chromatography (HPLC), Thin Layer Chromatography (HPTLC), and Gas Chromatography–Mass Spectrometry (GC– MS). To provide scientific evidence pharmacological and toxicological evaluations are involve for the therapeutic potential of herbal formulations. herbal products are available Several marketed compositions such as Nardostachys jatamansi, Bacopa monnieri, Lavandula angustifolia, Withania somnifera, etc these have property to prevent depressant, anxiety and so many diseases. The review highlights the present important the validation and standardization approaches used for marketed herbal formulations and also in this article summarizes previously studied formulations which was used in the management of depression and anxiety disorders.

Keywords : Herbal Formulations, Marketed Herbal Products, Depression, Anxiety Disorders, Herbal Drug Evaluation, Medicinal Plants

References :

1. Mhaske, S. R., Sitaphale, G. R., & Tathe, P. R. (2025). Review on standardization of herbal drug and formulation. International Journal of Creative Research Thoughts, 13(2), g700–g710.
2. AOAC. Official Methods of Analysis of AOAC International, 18th edn. AOAC International, Gaithersburg, MD; c2005.
3. Bai C.C., S.Y. Han, X.Y. Chai, Y. Jiang, P. Li, P.F. Tu, Sensitive determination of saponins in Radix et Rhizoma Notoginseng by charged aerosol detector coupled with HPLC, J. Liq. Chromatogr. Relat.Technol. 2009; 32: 242-260.
4. Calixto JB, Barz J. Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (Phytotherapeutic agents), Med Biol Res. 2000;33:179-189.
5. Chaudhury RR, Herbal medicine for human health. World Health Organization Geneva, CBS publishers and distributors LTD New Delhi, 1999. 5. Dasgupta P, and De A, Comparative Standardization Study of Two Marketed Ashwagandha Churna Formulation, International Journal of Research in Pharmaceutical and Biomedical Sciences, 2012; 3 (2): 734-741.
6. Dr. Rajesh Kumari, et al., Standardization of herbal medicines./ International Journal of Pharma Sciences and Research (IJPSR). 2016 Feb;7(02):100-102.
7. Dubey N K, Rajesh Kumar and Pramila Tripathi. Global promotion of herbal medicine: India.s opportunity. Current Science 2004; 86 (1): 37-41.
8. Ekka N R, Namdeo K P and Samal P K, Standardization Strategies for Herbal Drugs-An Overview, Research J. Pharm. and Tech. 2008; 1(4): 310-312.
9. Gatkal S, Punde A, Balap A, and Chaudhari,P, Safety of Herbal Medicine: A Review
10. Gautam A, Kashyap S J, Sharma P K, Garg V K, Visht S, Kumar N, Identification, evaluation and standardization of herbal drugs: A review, Der Pharmacia Lettre, 2010; 2(6): 302-315
11. World Health Organization (WHO).  Depression. Factsheet. Geneva, Switzerland: WHO; 2020
12. Kenda M, Kočevar Glavač N, Nagy M, Sollner Dolenc M. Medicinal Plants Used for Anxiety, Depression, or Stress Treatment: An Update. Molecules. 2022 Sep 15;27(18):6021. doi: 10.3390/molecules27186021. PMID: 36144755; PMCID: PMC9500625.
13. Arroll B., Chin W.Y., Martis W., Goodyear-Smith F., Mount V., Kingsford D., Humm S., Blashki G., Macgillivray S. Antidepressants for treatment of depression in primary care: A systematic review and meta-analysis. J. Prim. Health Care. 2016; 8:325–334. doi: 10.1071/HC16008.
14. Bandelow B., Michaelis S., Wedekind D. Treatment of anxiety disorders. Dialogues Clin. Neurosci. 2017; 19:93–107. doi: 10.31887/DCNS.2017.19.2/bbandelow.
15. Yeung K.S., Hernandez M., Mao J.J., Haviland I., Gubili J. Herbal medicine for depression and anxiety: A systematic review with assessment of potential psycho-oncologic relevance. Phyther. Res. 2018; 32:865–891. doi: 10.1002/ptr.6033.
16. Sartori S.B., Singewald N. Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders. Pharmacol. Ther. 2019;204:107402. doi: 10.1016/J.PHARMTHERA.2019.107402.
17. Montemurro N., Ricciardi L., Scerrati A., Castorina A., Nawrot J., Gornowicz-Porowska J., Budzianowski J., Nowak G., Schroeder G., Kurczewska J. Medicinal Herbs in the Relief of Neurological, Cardiovascular, and Respiratory Symptoms after COVID-19 Infection A Literature Review. Cells. 2022; 11:1897. doi: 10.3390/CELLS11121897.
18. Fajemiroye J.O., da Silva D.M., de Oliveira D.R., Costa E.A. Treatment of anxiety and depression: Medicinal plants in retrospect. Fundam. Clin. Pharmacol. 2016;30:198–215. doi: 10.1111/fcp.12186.
19. Esmail Al-Snafi A., Ali Talab T., Majid W.J. Medicinal Plants with Central Nervous Activity-An Overview (Part 1) IOSR J. Pharm. 2019;9:52–102.
20. Bocquet L., Sahpaz S., Hilbert J.L., Rambaud C., Rivière C. Humulus lupulus L., a very popular beer ingredient and medicinal plant: Overview of its phytochemistry, its bioactivity, and its biotechnology. Phytochem. Rev. 2018;17:1047–1090. doi: 10.1007/S11101-018-9584-Y.
21. Chadwiek L.R., Nikolic D., Burdette J.E., Overk C.R., Bolton J.L., Van Breemen R.B., Fröhlich R., Fong H.H.S., Farnsworth N.R., Pauli G.F. Estrogens and congeners from spent hops (Humulus lupulus) J. Nat. Prod. 2004;67:2024–2032. doi: 10.1021/np049783i.
22. Benkherouf A.Y., Soini S.L., Stompor M., Uusi-Oukari M. Positive allosteric modulation of native and recombinant GABA A receptors by hops prenylflavonoids. Eur. J. Pharmacol. 2019;852:34–41. doi: 10.1016/J.EJPHAR.2019.02.034.
23. Kyrou I., Christou A., Panagiotakos D., Stefanaki C., Skenderi K., Katsana K., Tsigos C. Effects of a hops (Humulus lupulus L.) dry extract supplement on self-reported depression, anxiety and stress levels in apparently healthy young adults: A randomized, placebo-controlled, double-blind, crossover pilot study. Hormones. 2017;16:171–180. doi: 10.14310/HORM.2002.1738.
24. Jacobs B.P., Bent S., Tice J.A., Blackwell T., Cummings S.R. An internet-based randomized, placebo-controlled trial of kava and valerian for anxiety and insomnia. Medicine. 2005;84:197–207. doi: 10.1097/01.md.0000172299.72364.95.
25. Sarris J., Stough C., Bousman C.A., Wahid Z.T., Murray G., Teschke R., Savage K.M., Dowell A., Ng C., Schweitzer I. Kava in the treatment of generalized anxiety disorder: A double-blind, randomized, placebo-controlled study. J. Clin. Psychopharmacol. 2013;33:643–648. doi: 10.1097/JCP.0b013e318291be67
26. Woelk H., Schläfke S. A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder. Phytomedicine. 2010;17:94–99. doi: 10.1016/j.phymed.2009.10.006.
27. Cases J., Ibarra A., Feuillère N., Roller M., Sukkar S.G. Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances. Med. J. Nutr. Metab. 2011;4:211–218. doi: 10.1007/s12349-010-0045-4.
28. Haybar H., Javid A.Z., Haghighizadeh M.H., Valizadeh E., Mohaghegh S.M., Mohammadzadeh A. The effects of Melissa officinalis supplementation on depression, anxiety, stress, and sleep disorder in patients with chronic stable angina. Clin. Nutr. ESPEN. 2018;26:47–52. doi: 10.1016/j.clnesp.2018.04.015.
29. Ghazizadeh J., Sadigh-Eteghad S., Marx W., Fakhari A., Hamedeyazdan S., Torbati M., Taheri-Tarighi S., Araj-khodaei M., Mirghafourvand M. The effects of lemon balm (Melissa officinalis L.) on depression and anxiety in clinical trials: A systematic review and meta-analysis. Phyther. Res. 2021;35:6690–6705. doi: 10.1002/ptr.7252.
30. Sarris J., Panossian A., Schweitzer I., Stough C., Scholey A. Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence. Eur. Neuropsychopharmacol. 2011;21:841–860. doi: 10.1016/j.euroneuro.2011.04.002.
31. Fatima, N., et al. (2023). Safety study of a pharmacopoeia-based Unani formulation for psychological diseases. International Journal of Research and Analytical Reviews, 10(3), 660–666.
32. Kean JD, Downey LA, Stough C. Systematic Overview of Bacopa monnieri (L.) Wettst. Dominant Poly-Herbal Formulas in Children and Adolescents. Medicines (Basel). 2017 Nov 22;4(4):86. doi: 10.3390/medicines4040086. PMID: 29165401; PMCID: PMC5750610.
33. Santhosh, C., Amritha, M. S., & Jones, H. (2021). A review on the neuroprotective action of Brahmi ghrita – A polyherbal Ayurvedic formulation. International Journal of Research and Analytical Reviews, 8(3), 9–13.
34. Bachour G, Samir A, Haddad S, Houssaini MA, El Radad M. Effects of Ashwagandha Supplements on Cortisol, Stress, and Anxiety Levels in Adults: A Systematic Review and Meta-Analysis. BJPsych Open. 2025;11(S1):S39-S39. doi:10.1192/bjo.2025.10136
35. Lyle N, Bhattacharyya D, Sur TK, Munshi S, Paul S, Chatterjee S, Gomes A. Stress modulating antioxidant effect of Nardostachys jatamansi. Indian J Biochem Biophys. 2009 Feb;46(1):93-8. PMID: 19374260.
36. Toolika E, Bhat NP, Shetty SK. A comparative clinical study on the effect of Tagara (Valeriana wallichii DC.) and Jatamansi (Nardostachys jatamansi DC.) in the management of Anidra (primary insomnia). Ayu. 2015 Jan-Mar;36(1):46-9. doi: 10.4103/0974-8520.169008. PMID: 26730138; PMCID: PMC4687238.
37. Kholghi, G., Arjmandi-Rad, S., Zarrindast, M. R., & Vaseghi, S. (2022). St. John’s wort (Hypericum perforatum) and depression: What happens to the neurotransmitter systems? Naunyn-Schmiedeberg's Archives of Pharmacology, 395, 629–642.
38. Kamble, S., Kherade, M., Rasala, T., Bijagare, S., Anjankar, R., Gadadhe, N., Khobragade, T., Gadge, S., & Sonkar, S. (2025). From tradition to modern science: A comprehensive review of Nardostachys jatamansi's therapeutic benefits and pharmacological activities. Journal of Pharmacognosy and Phytochemistry, 14(2), 590–596.
39. Pundarikakshudu K, Bhatt CJ. Design, Development and Rationalization of Sarpagandha Ghanvati. Indian J Pharm Sci. 2015 Sep-Oct;77(5):626-30. doi: 10.4103/0250-474x.169029. PMID: 26798180; PMCID: PMC4700718.
40. Sharma R, Singla RK, Banerjee S, Sinha B, Shen B, Sharma R. Role of Shankhpushpi (Convolvulus pluricaulis) in neurological disorders: An umbrella review covering evidence from ethnopharmacology to clinical studies. Neurosci Biobehav Rev. 2022 Sep;140:104795. doi: 10.1016/j.neubiorev.2022.104795. Epub 2022 Jul 22. PMID: 35878793.
41. Vaibhavi Diliprao Deshmukh, Rohan Rajesh Mirase, Pratap Namdev Munde, Trupti Sunil Varne, Mangesh Pandurang Munde, and Rasika Ramesh Patil, “Formulation and Evaluation of Novel Drug Delivery System of Passiflora Incarnata for Antianxiety Activity,” International Research Journal of Pharmacy and Medical Sciences (IRJPMS), Volume 7, Issue 4, pp. 39-48, 2024.
42. Kuchta K, Hladikova M, Thomsen M, Nahrstedt A, Schmidt M. Kava (Piper methysticum) Extract for the Treatment of Nervous Anxiety, Tension and Restlessness. Drug Res (Stuttg). 2021 Feb;71(2):83-93. doi: 10.1055/a-1268-7135. Epub 2020 Nov 18. PMID: 33207379.
43. Beck SM, Ruge H, Schindler C, Burkart M, Miller R, Kirschbaum C, Goschke T. Effects of Ginkgo biloba extract EGb 761® on cognitive control functions, mental activity of the prefrontal cortex and stress reactivity in elderly adults with subjective memory impairment - a randomized double-blind placebo-controlled trial. Hum Psychopharmacol. 2016 May;31(3):227-42. doi: 10.1002/hup.2534. PMID: 27147264; PMCID: PMC5084772.
44. Yoo, O., & Park, S.-A. (2023). Anxiety-Reducing Effects of Lavender Essential Oil Inhalation: A Systematic Review. Healthcare, 11(22), 2978.
45. Ivanova Stojcheva E, Quintela JC. The Effectiveness of Rhodiola rosea L. Preparations in Alleviating Various Aspects of Life-Stress Symptoms and Stress-Induced Conditions-Encouraging Clinical Evidence. Molecules. 2022 Jun 17;27(12):3902. doi: 10.3390/molecules27123902. PMID: 35745023; PMCID: PMC9228580.
46. Lopresti AL, Drummond PD.  Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action. Human Psychopharmacology 2014; 29(6): 517-527.
47. Donelli D, Antonelli M, Bellinazzi C, Gensini GF, Firenzuoli F. Effects of lavender on anxiety: A systematic review and meta-analysis. Phytomedicine. 2019 Dec; 65:153099. doi: 10.1016/j.phymed.2019.153099. Epub 2019 Sep 26. PMID: 31655395.
48. Noor-E-Tabassum, Das R, Lami MS, Chakraborty AJ, Mitra S, Tallei TE, Idroes R, Mohamed AA, Hossain MJ, Dhama K, Mostafa-Hedeab G, Emran TB. Ginkgo biloba: A Treasure of Functional Phytochemicals with Multimedicinal Applications. Evid Based Complement Alternat Med. 2022 Feb 28;2022:8288818. doi: 10.1155/2022/8288818. PMID: 35265150; PMCID: PMC8901348.
49. Ibáñez B, Melero A, Montoro A, Merino-Torres JF, Soriano JM, San Onofre N. A Narrative Review of the Herbal Preparation of Ayurvedic, Traditional Chinese, and Kampō Medicines Applied as Radioprotectors. Antioxidants (Basel). 2023 Jul 17;12(7):1437. doi: 10.3390/antiox12071437. PMID: 37507975; PMCID: PMC10376155.
50. Jain PK, Das D, Jain P, Jain P, Jain PK. Pharmacognostic and pharmacological aspect of Bacopa monnieri - a review. Innovare J Ayurvedic Sci. (2016) 4, 796-11.